Shearman & Sterling LLP | Antitrust Blog | Home | Section 7
Antitrust Litigation
This links to the home page

  • FTC Orders Biotechnology Company To Divest Cancer Detection Test Maker

    On April 3, 2023, the United States Federal Trade Commission (the “Commission”) voted unanimously to issue an Opinion and Order requiring Illumina, Inc. (the “Company”), to divest GRAIL, Inc. (together the “Parties”). The Opinion reversed the Administrative Law Judge’s (the “ALJ”) Initial Decision of September 1, 2022, which had dismissed the complaint brought by Commission staff alleging that the acquisition would reduce innovation and would likely harm competition.